In a rising interest rate environment, investors are increasingly turning to dividend stocks to shield their portfolios from further downside risks. Healthcare and pharmaceutical stocks that emerged from the Covid-19 pandemic with strong performance have been among the leaders of the pack and our latest reaffirmation in the Best Health Care Dividend Stocks List is no exception.
Thanks to strong corporate earnings, healthy growth in its drug pipeline and positive year-to-date performance for its stock, our big pharma pick is giving investors more reasons to be optimistic. Its market-beating dividend yield, which is more than twice the healthcare industry average, adds to the growing list of positive catalysts.
Our pick reported better-than-expected earnings and revenue numbers for the most recent fiscal quarter. Its stock is up double-digit percentages this year – and is still fairly valued based on its forward price-to-earnings ratio.
The stock is scheduled to go ex-dividend on Thursday, August 25 (estimated date).
You can check out the Best Health Care Dividend Stocks List to explore all the stocks.
